相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Amino Terminus of Herpes Simplex Virus 1 Glycoprotein K Is Required for Virion Entry via the Paired Immunoglobulin-Like Type-2 Receptor Alpha
Sona Chowdhury et al.
JOURNAL OF VIROLOGY (2013)
HSV-1 strain McKrae is more neuroinvasive than HSV-1 KOS after corneal or vaginal inoculation in mice
Hong Wang et al.
VIRUS RESEARCH (2013)
Herpes simplex virus type 1 is the main cause of genital herpes in women of Natal, Brazil
Valeska S. S. Pereira et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2012)
The challenge of developing a herpes simplex virus 2 vaccine
Lesia K. Dropulic et al.
EXPERT REVIEW OF VACCINES (2012)
Live Attenuated Herpes Simplex Virus 2 Glycoprotein E Deletion Mutant as a Vaccine Candidate Defective in Neuronal Spread
Sita Awasthi et al.
JOURNAL OF VIROLOGY (2012)
A vaccine strategy that protects against genital herpes by establishing local memory T cells
Haina Shin et al.
NATURE (2012)
Virus-cell fusion as a trigger of innate immunity dependent on the adaptor STING
Christian K. Holm et al.
NATURE IMMUNOLOGY (2012)
Efficacy Results of a Trial of a Herpes Simplex Vaccine
Robert B. Belshe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Immune epitope database analysis resource
Yohan Kim et al.
NUCLEIC ACIDS RESEARCH (2012)
Sensing herpes: more than toll
Jesper Melchjorsen
REVIEWS IN MEDICAL VIROLOGY (2012)
Development of a Glycoprotein D-Expressing Dominant-Negative and Replication-Defective Herpes Simplex Virus 2 (HSV-2) Recombinant Viral Vaccine against HSV-2 Infection in Mice
Natalie V. Akhrameyeva et al.
JOURNAL OF VIROLOGY (2011)
A Live-Attenuated HSV-2 ICP0- Virus Elicits 10 to 100 Times Greater Protection against Genital Herpes than a Glycoprotein D Subunit Vaccine
William P. Halford et al.
PLOS ONE (2011)
Immunization with a dominant-negative recombinant Herpes Simplex Virus (HSV) type 1 protects against HSV-2 genital disease in guinea pigs
Richard Brans et al.
BMC MICROBIOLOGY (2010)
The Herpes Simplex Virus Type 1 UL20 Protein and the Amino Terminus of Glycoprotein K (gK) Physically Interact with gB
Vladimir N. Chouljenko et al.
JOURNAL OF VIROLOGY (2010)
Prevention of Genital Herpes Simplex Virus Type 1 and 2 Disease in Mice Immunized with a gD-Expressing Dominant-Negative Recombinant HSV-1
Richard Brans et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
The Amino Terminus of Herpes Simplex Virus Type 1 Glycoprotein K (gK) Modulates gB-Mediated Virus-Induced Cell Fusion and Virion Egress
Vladimir N. Chouljenko et al.
JOURNAL OF VIROLOGY (2009)
Recombinant vesicular stomatitis virus-based west Nile vaccine elicits strong humoral and cellular immune responses and protects mice against lethal challenge with the virulent west Nile virus strain LSU-AR01
Arun V. Iyer et al.
VACCINE (2009)
Innate and Adaptive Immune Responses to Herpes Simplex Virus
Tracy Chew et al.
VIRUSES-BASEL (2009)
The Role of a Glycoprotein K (gK) CD8+ T-Cell Epitope of Herpes Simplex Virus on Virus Replication and Pathogenicity
Kevin R. Mott et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2009)
The herpes simplex virus type 1 (HSV-1) glycoprotein K(gK) is essential for viral corneal spread and neuroinvasiveness
Andrew T. David et al.
CURRENT EYE RESEARCH (2008)
The potential impact of a prophylactic herpes simplex vaccine
Richard Rupp et al.
EXPERT OPINION ON EMERGING DRUGS (2008)
Functional and physical interactions of the herpes simplex virus type 1 UL20 membrane protein with glycoprotein K
Timothy P. Foster et al.
JOURNAL OF VIROLOGY (2008)
A replication-competent, neuronal spread-defective, live attenuated herpes simplex virus type 1 vaccine
Elizabeth E. Brittle et al.
JOURNAL OF VIROLOGY (2008)
Asymptomatic Human CD4+ Cytotoxic T-Cell Epitopes Identified from Herpes Simplex Virus Glycoprotein B
Aziz Alami Chentoufi et al.
JOURNAL OF VIROLOGY (2008)
Comparison of immunogenicity and protective efficacy of genital herpes vaccine candidates herpes simplex virus 2 dl5-29 and dl5-29-41L in mice and guinea pigs
Yo Hoshino et al.
VACCINE (2008)
Disruption of the UL41 gene in the herpes simplex virus 2 dl5-29 mutant increases its immunogenicity and protective capacity in a murine model of genital herpes
Timothy Dudek et al.
VIROLOGY (2008)
A recombinant herpes simplex virus type 1 expressing two additional copies of gK is more pathogenic than wild-type virus in two different strains of mice
Kevin R. Mott et al.
JOURNAL OF VIROLOGY (2007)
Immunization with a replication-defective herpes simplex virus 2 mutant reduces herpes simplex virus 1 infection and prevents ocular disease
Allison L. van Lint et al.
VIROLOGY (2007)
The herpes simplex virus UL20 protein functions in glycoprotein K (gK) intracellular transport and virus-induced cell fusion are independent of UL20 functions in cytoplasmic virion envelopment
Jeffrey M. Melancon et al.
VIROLOGY JOURNAL (2007)
Residual antigen presentation after influenza virus infection affects CD8 T cell activation and migration
DJ Zammit et al.
IMMUNITY (2006)
Evaluation of AD472, a live attenuated recombinant herpes simplex virus type 2 vaccine in guinea pigs
MN Prichard et al.
VACCINE (2005)
CD69 is an immunoregulatory molecule induced following activation
D Sancho et al.
TRENDS IN IMMUNOLOGY (2005)
Herpes simplex virus type 1 gK is required for gB-mediated virus-induced cell fusion, while neither gB and gK nor gB and UL20p function redundantly in virion de-envelopment
JM Melancon et al.
JOURNAL OF VIROLOGY (2005)
The herpes simplex virus type 1 UL20 protein modulates membrane fusion events during cytoplasmic virion morphogenesis and virus-induced cell fusion
TP Foster et al.
JOURNAL OF VIROLOGY (2004)
Herpes simplex virus type 1 glycoprotein K and the UL20 protein are interdependent for intracellular trafficking and trans-Golgi network localization
TP Foster et al.
JOURNAL OF VIROLOGY (2004)
The dominant-negative herpes simplex virus type 1 (HSV-1) recombinant CJ83193 can serve as an effective vaccine against wild-type HSV-1 infection in mice
H Augustinova et al.
JOURNAL OF VIROLOGY (2004)
Increasing proportion of herpes simplex virus type 1 as a cause of genital herpes infection in college students
CM Roberts et al.
SEXUALLY TRANSMITTED DISEASES (2003)
Is herpes simplex virus type 1 (HSV-1) now more common than HSV-2 in first episodes of genital herpes?
GJ Mertz et al.
SEXUALLY TRANSMITTED DISEASES (2003)
Progesterone increases susceptibility and decreases immune responses to genital herpes infection
C Kaushic et al.
JOURNAL OF VIROLOGY (2003)
Plasma membrane topology of syncytial domains of herpes simplex virus type 1 glycoprotein K (gK): the UL20 protein enables cell surface localization of gK but not gK-mediated cell-to-cell fusion
TP Foster et al.
JOURNAL OF VIROLOGY (2003)
Recent progress in herpes simplex virus immunobiology and vaccine research
DM Koelle et al.
CLINICAL MICROBIOLOGY REVIEWS (2003)
Projection of the future dimensions and costs of the genital herpes simplex type 2 epidemic in the United States
DN Fisman et al.
SEXUALLY TRANSMITTED DISEASES (2002)
Comparison of different forms of herpes simplex replication-defective mutant viruses as vaccines in a mouse model of HSV-2 genital infection
XJ Da Costa et al.
VIROLOGY (2001)
分享论文
